Finding. IDH1-mutant gliomas are usually called slow because they drown in 2-hydroxyglutarate. Bajaj and Karnati say the one-carbon network still splits them. Across 709 TCGA and CGGA transcriptomes, 64 one-carbon genes draw two mutant states: a suppressed metabolic phenotype leaning on compensatory mitochondrial pathways, and a minority that turns proliferative one-carbon genes up. That high composite score tracks worse survival in the CGGA mutant cohort (hazard ratio 1.61). U87 R132H cells are the dish check. CIBERSORTx is the immune overlay.
Why this paper matters
IDH inhibitors assume a shared mutant metabolism. A score that finds an aggressive one-carbon subset inside that bin is a reason some mutants will look “IDH-inhibitor-refractory” for reasons that are not about 2-HG occupancy. The authors’ own translational sentence is metabolic precision: indolent mitochondrial-dependent tumors versus proliferation-dependent ones.
How to read the score
Mid-seventies. Real mitochondrial framing (compensation in the quiet state), a survival split, a 64-gene object. Confidence is medium: abstract truncated, bulk RNA, U87. This is a stratification brief, not a new oncometabolite.
Caveats
Hazard ratios without the rest of the Cox table are a teaser. Cell-line dependency is not a patient avatar. Do not withhold IDH inhibitors from a high-OCM patient because of this brief.
What to do with it
If you bin IDH1-mutant gliomas, add an one-carbon score next to 1p/19q and grade. If you look for mitochondrial dependencies, the quiet mutant state is the one they call mitochondrially supported. Read the in-vitro validation figures the abstract cannot finish.